NATURES SUNSHINE PRODUCTS INC (NATR)

↓ Download CSV

CIK 0000275053 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Dec 31

In fiscal 2025, NATURES SUNSHINE PRODUCTS INC reported revenue of $480.14M, up 5.7% from the prior year. The company was profitable, with a net margin of 4.3% and a gross margin of 72.4%. It held $261.15M in total assets against $99.59M in total liabilities.

Key ratios (FY2025)

72.4%
Gross margin
5.2%
Operating margin
4.3%
Net margin
12.7%
Return on equity
+5.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$480.14M$454.36M$445.32M$421.91M$444.08M$385.20M$362.21M$364.81M$342.03M$341.16M
Cost of Revenue$132.42M$129.68M$124.19M$122.15M$115.47M$101.28M$93.94M$95.69M$91.04M$90.94M
Gross Profit$347.72M$324.69M$321.13M$299.76M$328.62M$283.93M$268.27M$269.12M$250.99M$250.22M
Operating Income$24.74M$20.09M$18.75M$16.26M$34.67M$21.48M$16.12M$5.35M$1.39M$10.04M
Net Income$20.45M$7.89M$16.42M$550.0K$30.21M$22.96M$6.93M-$1.20M-$13.82M$675.0K
EPS (Diluted)$1.06$0.40$0.77$-0.02$1.42$1.07$0.34$-0.04$-0.69$0.11
Total Assets$261.15M$240.85M$249.77M$229.78M$258.87M$249.50M$213.07M$193.02M$195.19M$205.57M
Total Liabilities$99.59M$79.86M$90.23M$82.73M$97.47M$92.26M$83.63M$72.45M$75.46M$73.17M
Shareholders' Equity$161.55M$160.99M$159.54M$147.05M$161.40M$157.23M$129.44M$120.57M$119.73M$132.40M
Cash & Equivalents$93.89M$84.70M$82.37M$60.03M$86.18M$92.07M$53.63M$50.64M$42.91M$32.28M
Operating Cash Flow$35.32M$25.30M$41.23M$710.0K$34.61M$37.66M$8.54M$21.83M$10.52M$3.42M
Capital Expenditures$6.48M$10.97M$10.48M$7.63M$6.67M$4.91M$5.10M$4.83M$5.50M$11.03M
Shares Outstanding18.47M19.09M19.47M19.33M20.33M19.97M19.66M19.12M18.88M19.06M
Dividends Per Share$0.00$1.00$0.00$0.00$0.00$0.10$0.40